earnings
confidence high
sentiment negative
materiality 0.75
Pharma-Bio Serv Q3 revenue falls to $2.4M, swings to net loss of $0.3M
Pharma-Bio Serv, Inc.
2025-Q3 EPS
reported $0.04
vs consensus $0.03
▲ beat
(+14.4%)
- Q3 revenue $2.4M, down ~$2.2M (48%) from $4.6M in same quarter last year.
- Net loss of $0.3M compared to net income of $0.5M in Q3 last year.
- Nine-month revenue $7.2M (down $6.2M); net loss $0.8M vs net income $1.4M.
- CEO cites challenging investment environment; investing in tech tools to return to profitability.